Detalles de la búsqueda
1.
Coinfection with Streptococcus pneumoniae modulates the B cell response to influenza virus.
J Virol
; 88(20): 11995-2005, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25100838
2.
Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.
PLoS Pathog
; 9(3): e1003207, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23516357
3.
Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection.
J Immunol
; 184(9): 5151-9, 2010 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20368274
4.
Pharmacologic activation of the innate immune system to prevent respiratory viral infections.
Am J Respir Cell Mol Biol
; 45(3): 480-8, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21148741
5.
Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse.
Virol J
; 4: 118, 2007 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-17974006
6.
Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.
Mol Immunol
; 43(14): 2195-206, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16472860
7.
Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.
Virol J
; 3: 102, 2006 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-17150104
8.
Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease.
Virology
; 462-463: 254-65, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24999050
9.
Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.
PLoS One
; 6(12): e28445, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22180783
10.
Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI.
J Clin Invest
; 121(10): 3954-64, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21881204
11.
Prospects for universal influenza virus vaccine.
Emerg Infect Dis
; 12(4): 569-74, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16704803
12.
Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components.
Virology
; 352(2): 418-26, 2006 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16777168
13.
Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.
J Virol
; 79(11): 6644-54, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15890902
14.
Roles of CD4+ T-cell-independent and -dependent antibody responses in the control of influenza virus infection: evidence for noncognate CD4+ T-cell activities that enhance the therapeutic activity of antiviral antibodies.
J Virol
; 79(10): 5943-51, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15857980
15.
Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice.
J Virol
; 77(15): 8322-8, 2003 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12857901
16.
Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype.
J Virol
; 76(3): 1369-78, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11773411
17.
Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.
Vaccine
; 21(19-20): 2616-26, 2003 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-12744898
Resultados
1 -
17
de 17
1
Próxima >
>>